The 2019 G-FINDER Report: “[This] project has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development (R&D) of new products to prevent, diagnose, control or cure neglected diseases in developing countries. It provides an up-to-date analysis of how R&D investments are being allocated across diseases and product types, funding trends over time, and where the potential gaps lie. This is the twelfth annual G-FINDER report, providing new data on investments made in financial
year 2018. In all, 262 organisations completed the survey for FY2018, which covered 36 neglected diseases and all relevant product types – drugs, vaccines, biologics, diagnostics, microbicides and vector control products (chemical and biological control agents, and reservoir targeted vaccines) – as well as basic research.”
“This case study looks at the challenges faced in sustaining HIV prevention programmes among KAPs, implemented primarily by civil society organisations (CSO’s), as a result of the withdrawal of the Global Fund through the transition period of 2020 to 2022 and the lack of government capacity and resources to maintain the already limited services that will likely result in the re-emergence of HIV epidemics among people who inject drugs (PWID), sex workers (SW) and men who have sex with men (MSM).”
People with HIV, tuberculosis and malaria talk about their experiences and the connection between human rights and HIV work.
Our friends at Action Against AIDS conducted three interviews to discuss the connections between human rights and HIV work. The videos, embedded below, highlight the needs of people who are all too often marginalized and emphasize the need to focus on human rights principles. The interviewees share their concerns if we loose focus and start to chip away the gains we have made.